Emergent Biosolutions EBS Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.8M— | —— | $51.2M+527% | -$12M-118% | $68M+317% | ||
| $23.5M0.0% | $23.5M+0.4% | $23.4M-0.4% | $23.5M-7.5% | $25.4M-2.3% | ||
| $1.9M-64.2% | $5.3M+10.4% | $4.8M+4.3% | $4.6M+207% | $1.5M-65.1% | ||
| -$33.8M-144% | $77.7M— | $0-100% | $106.4M+1,050% | -$11.2M— | ||
| $2.4M-38.5% | $3.9M+14.7% | $3.4M+17.2% | $2.9M-19.4% | $3.6M+112% | ||
| -$2.4M— | —— | —— | $17.2M-71.1% | $59.5M+108% | ||
| $9M-1.1% | $9.1M+2.2% | $8.9M+29.0% | $6.9M— | $0— | ||
| -$11.4M+90.0% | -$113.9M-616% | -$15.9M-148% | -$6.4M-1,500% | -$400K— | ||
| -$47.6M— | —— | —— | $118.2M+150% | $47.2M+193% | ||
| -$36.2M-149% | $73.8M— | $0-100% | $103.5M+799% | -$14.8M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Emergent Biosolutions generate?
- Emergent Biosolutions (EBS) generated $150.3M in operating cash flow over the trailing twelve months.
- What is Emergent Biosolutions's free cash flow?
- After $12.6M of capital expenditures, Emergent Biosolutions's free cash flow was $141.1M over the trailing twelve months, up 310.0% year over year.
- Where does Emergent Biosolutions's cash flow data come from?
- Every line is extracted from Emergent Biosolutions's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
